Every developing story NewsAI is tracking for pharmaceuticals — as timelines, not a pile of articles.
This article was published on April 14, 2026 The Luxembourg-founded startup is already in production with multiple top-20 global pharma companies, including a public collaboration…
Patented medicines will face a 100% tariff entering the US - but companies can still avoid the taxes by striking deals with the administration, the White House has said. US…
President Donald Trump claimed that his tariffs were the reason for Novartis AG, a Swiss pharmaceutical company, to expand its manufacturing operations in the United States. This…
The article discusses French President Emmanuel Macron's call for the European Union (EU) to take a stronger stance against US President Donald Trump's policies. Macron argues…
The article discusses several news stories from different parts of the world, with a focus on the UK political landscape. The main story is about Andy Burnham, the "King of the…
The article highlights concerns raised by UK MPs about the government's dealings with former US President Donald Trump. They warn that the UK's agreements with Trump are "built on…
The FDA has announced a new initiative that will provide fast-track reviews for nine drug manufacturers. This program aims to reward companies that align with the Trump…
The article reports that major pharmaceutical companies have paused or abandoned nearly £2 billion in planned investments in the UK this year. This includes MSD's decision to…
The article discusses the potential impact of President Trump's proposed pharmaceutical tariffs on the production of common drugs in the United States. It highlights that many of…
First Solar, a major solar panel manufacturer, has reportedly become stronger due to the recent tax-and-spending law enacted under the Trump administration, rather than the 2022…
AstraZeneca, a leading U.K. pharmaceutical company, has announced plans to invest $50 billion in the United States. This move comes amidst the ongoing trade tensions between the…
The most recent articles mentioning pharmaceuticals, grouped by month. Open a story above to read it as a full timeline.
This article was published on April 14, 2026 The Luxembourg-founded startup is already in production with multiple top-20 global pharma companies, including a public collaboration…
Patented medicines will face a 100% tariff entering the US - but companies can still avoid the taxes by striking deals with the administration, the White House has said. US…
President Donald Trump claimed that his tariffs were the reason for Novartis AG, a Swiss pharmaceutical company, to expand its manufacturing operations in the United States. This…
The IRS has granted a significant tax break to tech and pharmaceutical companies, allowing them to benefit from President Trump's research and development (R&D) deduction without…
The UK government is facing increasing pressure to reveal the details of its deal with the United States regarding the cost of medicines. Critics claim that the government is…
The article highlights concerns raised by UK MPs about the government's dealings with former US President Donald Trump. They warn that the UK's agreements with Trump are "built on…
The article discusses the challenges in reviving domestic drug manufacturing in the United States, as envisioned by President Trump. It focuses on a shuttered generic drug factory…
The FDA has announced a new initiative that will provide fast-track reviews for nine drug manufacturers. This program aims to reward companies that align with the Trump…
The article discusses the potential impact of Donald Trump's threats on the UK's pharmaceutical industry and the National Health Service (NHS). It highlights how Trump's proposal…
The article reports that major pharmaceutical companies have paused or abandoned nearly £2 billion in planned investments in the UK this year. This includes MSD's decision to…
The article discusses the ongoing debate within the Trump administration regarding potential measures to crackdown on the importation of medicines from China. It highlights the…
The article discusses the potential impact of President Trump's proposed pharmaceutical tariffs on the production of common drugs in the United States. It highlights that many of…
The article discusses the potential impact of President Trump's tariffs on Ireland, where many American drug companies have set up operations to take advantage of the country's…
The article discusses the tariff drama between Switzerland and the United States. Initially, on July 4th, Switzerland's top ministers believed they had secured a deal to avoid…
The Trump administration has imposed a 15% tariff on pharmaceutical products manufactured in Europe, posing a significant financial burden on drugmakers. This move is expected to…
AstraZeneca, a leading U.K. pharmaceutical company, has announced plans to invest $50 billion in the United States. This move comes amidst the ongoing trade tensions between the…
